CPC A61K 38/17 (2013.01) [A61K 31/436 (2013.01); A61K 31/519 (2013.01); A61K 38/1709 (2013.01); A61K 47/46 (2013.01); A61P 35/00 (2018.01); C07K 14/4702 (2013.01); C12N 7/00 (2013.01); C12N 2750/14143 (2013.01)] | 11 Claims |
1. A method for treating cancer comprising administering a modified protein, a polynucleotide encoding the modified protein, a vector carrying the polynucleotide, or a virus or cell transformed with the vector, in a pharmaceutically effective amount to a subject in need thereof,
wherein the modified protein is a Runx3 (Runt-related transcription factor 3) protein in which the 356th serine according to SEQ ID NO: 2 is substituted with an amino acid that cannot be phosphorylated by a kinase, and wherein the cancer is lung, stomach, or pancreatic cancer.
|